Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-141736)

Filing Details

Accession Number:: 0001104659-16-141736
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-29 06:00:37
Reporting Period:: 2016-08-25

Filing Date:: 2016-08-29
Accepted Time:: 2016-08-29 06:00:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Kalobios Pharmaceuticals Inc	KBIO	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1525354	Martin Shkreli	245 East 40Th Street, Apt. 18H New York NY 10016		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-25	1,913,206	$3.10	309,723	No	4	S	Direct
Common Stock	Disposition	2016-08-26	309,723	$3.10	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

On August 25, 2016 and August 26, 2016, Martin Shkreli sold all 1,913,206 shares of Common Stock of Kalobios Pharmaceuticals, Inc. that he then beneficially owned in private transactions.